TP53 mutation-biased CD8(+) T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma. Su X, Jin K, Zeng H, Liu Z, et al. Br J Cancer 2026;135:1131-1139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Su X, Jin K, Zeng H, Liu Z, et al. TP53 mutation-biased CD8(+) T cell exhaustion drives lethal outcome and therapy resistance in urothelial carcinoma. Br J Cancer 2026;135:1131-1139.
PMID: 42436321